Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Sensational artemisinin-piperaquine for treatment of COVID-19 in prospect 2021-11-03 22:42
TransThera Receives Fast Track Designation from FDA for its Core Product TT-00420 to Treat Cholangiocarcinoma 2021-11-03 22:00
ERT and Bioclinica become Clario, The Leading Technology Solutions Company for Clinical Trial Innovation and Evidence 2021-11-03 21:33
Standigm Files PCT Patent Application of AI-driven Repurposed Drugs for Primary Mitochondrial Disease 2021-11-03 21:00
I-Mab Announces Upcoming Participation at November Conferences 2021-11-03 20:00
BioKangtai's adenovirus vector COVID-19 vaccine obtained EUA in Indonesia 2021-11-03 19:02
Tabernacle Health Group Launches Revolutionary Immunity Booster! 2021-11-03 10:00
Kintor Pharma Doses First Patient in Clinical Trial of ALK-1 in Combination with KN046 In Advanced or Refractory Solid Tumors 2021-11-03 08:32
Daewoong's "Leaps and Bounds" Q3 Performance, Exceeds KRW 20B in Operating Income for Three Consecutive Quarters 2021-11-02 21:00
PD-1/VEGF Bi-Specific Antibody (AK112) Obtained Approval to Initiate a Phase II Clinical Trial for Monotherapy or Combined Chemotherapy Neoadjuvant/Adjuvant Therapy of Resectable Non-Small Cell Lung Cancer 2021-11-02 11:53
Antengene Granted IND Approval in China for the Phase Ib Study of ATG-008 (Onatasertib) in Combination with ATG-010 (Selinexor) in Patients with Diffuse Large B-Cell Lymphoma 2021-11-02 08:30
111 to Announce Third Quarter 2021 Unaudited Financial Results on November 19, 2021 - Conference Call to Follow 2021-11-02 04:57
Qilian International Holding Group Limited Donates Pharmaceutical Products Gan Di Xin® Worth RMB500,000 and Other Materials to Help Fight Local COVID-19 Epidemic 2021-11-01 20:00
I-Mab Strengthens Senior Executive Team with New Chief Financial Officer and Chief Strategy Officer Appointments 2021-11-01 20:00
Bionomics Receives FDA Clearance of IND for Evaluation of BNC210 in a Phase 2 Social Anxiety Disorder PREVAIL Study 2021-11-01 18:00
Farrer Park Hospital Introduced Actinium-225 PSMA Nuclear Therapy for Advanced Prostate Cancer 2021-11-01 08:15
Everest Medicines Announces Share Repurchase Transaction Details 2021-11-01 08:00
Operating Income of Yiling Pharmaceutical in First 3 Quarters Reaches CNY 8.112 Billion, Up 25.81% 2021-10-29 17:17
3M Health Care and Thermo Fisher Scientific Collaborate to Increase Process Efficiency and Scalability in Commercial Therapeutic Manufacturing 2021-10-29 15:45
IMPACT Therapeutics Announced ATR Inhibitor IMP9064 IND Clearance by FDA 2021-10-29 14:12
1 301 302 303 304 305 500